Lead Researcher Spotlight Professor Predrag Sikiric, MD, PhD (BPC-157 Primary Investigator) Department of Pharmacology University of Zagreb School of Medicine, Zagreb, Croatia Professor Predrag Sikiric has been the primary investigator for BPC-157 research since the 1990s, leading the team that isolated and characterized this peptide from human gastric juice
Studies suggest subcutaneous administration achieves 7085% bioavailability compared to oral routes, though oral protocols at 100150mg compensate for first-pass metabolism
That context, determined by nutrition, activity, sleep, and metabolic health, either supports or undermines the nerve repair processes peptides are trying to promote
5-Amino-1MQ works through a different and more upstream metabolic pathway
'My dream was to be a fitness influencer and I loved travelling and wearing bikinis
refrigerate or freeze for long-term research use Intended Use : In vitro assays, animal model studies, regenerative medicine research only This BPC-157 TB-500 10mg blend is supplied exclusively for laboratory research to support investigations into peptide-mediated healing, angiogenesis, and tissue regeneration